![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
Molecular Weight | 5917 g/mol |
---|---|
Molecular Formula | C267H402N64O76S6 |
XLogP3 | -3.5 |
Hydrogen Bond Donor Count | 76 |
Hydrogen Bond Acceptor Count | 87 |
Rotatable Bond Count | 189 |
Exact Mass | 5914.7950469 g/mol |
Monoisotopic Mass | 5912.7883372 g/mol |
Topological Polar Surface Area | 2400 Ų |
Heavy Atom Count | 413 |
Formal Charge | 0 |
Complexity | 14700 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 50 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
1 of 4 | |
---|---|
Drug Name | Levemir |
PubMed Health | Insulin Detemir (Injection) |
Drug Label | LEVEMIR (insulin detemir [rDNA origin] injection) is a sterile solution of insulin detemir for use as an injection. Insulin detemir is a long-acting basal insulin analog, with up to 24 hours duration of action, produced by a proceb that includes e... |
Active Ingredient | Insulin detemir recombinant; Insulin detemir |
Dosage Form | Injectable |
Route | injection; Subcutaneous |
Strength | 100 units/ml; 1000 units/10ml (100 units/ml) |
Market Status | Prescription |
Company | Novo Nordisk |
2 of 4 | |
---|---|
Drug Name | Levemir flexpen |
Active Ingredient | Insulin detemir recombinant |
Dosage Form | Injectable |
Route | Subcutaneous |
Strength | 300 units/3ml (100 units/ml) |
Market Status | Prescription |
Company | Novo Nordisk |
3 of 4 | |
---|---|
Drug Name | Levemir |
PubMed Health | Insulin Detemir (Injection) |
Drug Label | LEVEMIR (insulin detemir [rDNA origin] injection) is a sterile solution of insulin detemir for use as an injection. Insulin detemir is a long-acting basal insulin analog, with up to 24 hours duration of action, produced by a proceb that includes e... |
Active Ingredient | Insulin detemir recombinant; Insulin detemir |
Dosage Form | Injectable |
Route | injection; Subcutaneous |
Strength | 100 units/ml; 1000 units/10ml (100 units/ml) |
Market Status | Prescription |
Company | Novo Nordisk |
4 of 4 | |
---|---|
Drug Name | Levemir flexpen |
Active Ingredient | Insulin detemir recombinant |
Dosage Form | Injectable |
Route | Subcutaneous |
Strength | 300 units/3ml (100 units/ml) |
Market Status | Prescription |
Company | Novo Nordisk |